Bharat Serums and Vaccines (BSV) has opened a world-class R&D centre at Airoli, Maharashtra. The state-of-art centre was inaugurated by Rajesh Tope, Maharashtra's Health Minister. Also present at the event were Sanjiv Navangul, MD & CEO, BSV, Vishwanath Swarup, COO, India Business and Dr Jaby Jacob, Head, R&D. 

The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems that deliver better patient outcomes in women’s health, assisted reproductive technology and critical care and emergency medicines. 

Rajesh Tope, Health Minister, State of Maharashtra said, “The collaboration demonstrated by BSV during the pandemic, with the manufacturing of Liposomal Amphotericin B, has helped in saving lives and managing the pandemic.  It is also encouraging to hear of BSV’s ongoing COVID-19 Antibody development that will prepare us to fight the future COVID waves, as we continue to meet the unmet healthcare needs of our people.

He added, “With a renewed focus on strengthening women’s health in Maharashtra, we are proud of BSV’s first in the world Anti-Rho (D) immunoglobulin product that has assisted in safe deliveries and in bringing good health to Rh-negative mothers and new-borns in our state. Looking forward, we would like to build a patient-centred, innovation-driven, robust healthcare ecosystem in Maharashtra where companies such as BSV will be able to innovate and bring scientifically advanced products to India and the world.”